Aflac’s Japan Business in Focus as Investors Watch for a Strong First-Quarter Earnings Performance

Aflac is heading into its first-quarter earnings report with investors paying especially close attention to one key area: Japan. The insurer has long depended on its Japanese operations as a major source of revenue and profit, so any sign of strength there can have a meaningful effect on the company’s overall results. Recent analyst commentary has highlighted the possibility that improvements in Aflac’s Japan business could help the company post a better-than-expected quarter. That view is rooted in trends involving expenses, investment income, product performance, and the company’s ability to manage currency and portfolio pressure.

Why Japan Matters So Much to Aflac

Aflac is not just a U.S. supplemental insurer. Its Japanese business is central to the company’s identity and earnings profile. In investor materials, Aflac has described Japan as a market where it insures roughly one in four households and holds a leading position in cancer and medical insurance. That market position gives Aflac a strong base, but it also means that quarterly performance in Japan can heavily influence how Wall Street views the whole company.

The Japan segment has historically contributed a large share of Aflac’s profits. Even when premium growth slows, the business can still support earnings if management keeps costs under control, maintains solid margins, and earns healthy returns on investments. Because of that, analysts often look beyond headline revenue and focus more closely on pretax adjusted earnings, expense ratios, investment income, and product sales trends coming from Japan.

The Core Question Ahead of Earnings

The major question ahead of the quarter is simple: can Aflac’s Japan operations do enough to help the company beat expectations? Analyst previews have suggested that the answer could be yes, especially if the unit benefits from lower expenses and stronger investment income. A better expense ratio in Japan has been one of the most closely watched themes, because even modest improvement there can support margins in a meaningful way.

That optimism does not mean the business is free of pressure. Net earned premiums in Japan have faced headwinds from policies reaching paid-up status and from reinsurance-related effects. Still, if profit margins hold firm and investment income improves, Aflac may be able to offset those weaker premium trends enough to produce a respectable quarter.

Expense Control Could Be a Big Earnings Driver

Japan’s expense ratio has shown signs of improvement

One of the strongest arguments in favor of a solid quarter is expense management. Aflac’s prepared remarks for first-quarter 2024 noted that its Japan expense ratio was 18.0%, down 170 basis points year over year. Management said that improvement was driven primarily by good expense control and, to some extent, by expense allowance from reinsurance transactions. That is important because a lower expense ratio means more of every premium dollar can flow through to profit.

For investors, this matters even more in a period when premium growth is not especially strong. When top-line pressure exists, disciplined cost control becomes one of the most effective ways to protect earnings. If Aflac can repeat that pattern in the quarter under review, it would strengthen the case that the Japan business remains highly resilient even in a complicated operating environment.

Efficiency can soften pressure from weaker premium trends

Aflac’s Japan business has had to deal with a gradual drag from limited-pay products moving into paid-up status. In simple terms, some policies stop generating the same level of ongoing premiums once they reach that stage. That creates pressure on reported net earned premiums. But if the company reduces costs and maintains strong underwriting discipline, it can still generate healthy profits despite that drag.

This is why investors will likely pay close attention not only to reported sales or premium numbers, but also to the quality of earnings underneath them. A quarter with weaker premiums but stronger margins may still be viewed positively if it suggests the business is being managed well and remains highly cash generative.

Investment Income May Also Support Results

Adjusted net investment income has been an important lever

Another key variable is investment income. Aflac invests heavily to support its insurance operations, and returns from that portfolio can materially influence quarterly earnings. In Aflac’s first-quarter 2024 prepared remarks, management said adjusted net investment income in yen terms rose 19.3%, helped by lower hedge costs, the favorable impact of foreign exchange on U.S. dollar investments in yen terms, and a higher return on the variable income portfolio.

That improvement matters because investment income can help counter softer premium trends. If the company earns more from its portfolio while keeping expenses in line, the Japan unit can still post solid pretax adjusted earnings. That is one reason analysts saw room for optimism heading into the earnings release.

Portfolio and hedging decisions are especially important in Japan

Aflac’s Japan business operates in a market with low interest rates and meaningful currency considerations. As a result, the company’s hedging costs, yield management, and allocation decisions matter a lot. The company has noted in more recent disclosures that adjusted net investment income can be affected by floating-rate asset income, variable investment income, and currency-related factors. Those moving pieces can sometimes mask the underlying operating strength of the insurance franchise, which is why analysts often examine them carefully before and after earnings.

If investment results come in better than expected, even by a modest amount, they could provide the extra lift needed for Aflac to clear consensus estimates.

Premiums Remain a Pressure Point

Paid-up policies have weighed on net earned premiums

While there are reasons for optimism, there are also some notable risks. Aflac’s disclosures have shown that net earned premiums in Japan have been pressured by limited-pay products reaching paid-up status. In the company’s first-quarter 2024 results, net earned premiums in yen declined 5.0%, and in dollar terms they fell 16.3%, reflecting both business factors and exchange-rate impacts.

This matters because investors generally prefer to see stable or growing premium revenue from large insurance segments. Falling premiums can create concern that the business is maturing or losing momentum, even if profit margins remain sound. That said, the market may be willing to look past some premium weakness if management shows that the decline is largely structural and expected, rather than a sign of deteriorating demand.

Currency can make the headline numbers look worse

The yen has also been a major factor in how Aflac’s Japan results appear in U.S. dollar terms. In first-quarter 2024, the company said the average yen/dollar exchange rate was 148.67, around 11.0% weaker than the 132.30 average in the year-earlier period. A weaker yen reduces the translated value of Japanese earnings and premiums when reported in dollars, even if local-currency performance is more stable.

That translation effect is important for anyone analyzing Aflac. Sometimes a quarter can look soft in dollar terms while the underlying yen-based business is performing better than the headline suggests. Investors who understand that distinction may judge the quarter more favorably if local operating metrics remain healthy.

Sales Trends Offer a Mixed but Important Signal

New product momentum can shape the medium-term story

Sales are another important piece of the puzzle. In some periods, Aflac’s Japan segment has benefited from strong demand for newer products. In fourth-quarter 2025, for example, the company said Japan sales rose 15.7% to ¥19.9 billion, helped mainly by continued strong sales of Miraito, its new cancer insurance product. For the full year, sales were up 16.0% to ¥74.4 billion.

That matters because new sales today help determine future premium streams and earnings stability. If newer offerings like Miraito continue to resonate with customers, Aflac may be able to offset some of the runoff from older limited-pay products over time. In other words, premium pressure in the current quarter does not necessarily mean the franchise is weakening over the longer term.

But near-term sales have not always been smooth

The picture has not been uniformly strong. In first-quarter 2024, Aflac Japan’s new annualized premium sales declined 5.1% to ¥12.5 billion, or $84 million, with weaker first-sector sales contributing to the drop. That shows the Japan business is still navigating uneven demand conditions and product mix changes.

For investors looking ahead to earnings, this means the quality of the sales discussion on management’s conference call may be almost as important as the quarterly numbers themselves. Strong commentary about product traction, campaigns, and customer demand could reassure the market that the Japan business remains positioned for recovery and steady growth.

How Japan Compares With Aflac’s U.S. Business

Aflac’s U.S. business has recently provided a useful counterbalance. In fourth-quarter 2025, Aflac U.S. posted 4.0% growth in net earned premiums to $1.5 billion, while adjusted revenues rose 3.3%. That kind of stability can help offset fluctuations in Japan. Still, because Japan remains such a large contributor to pretax adjusted earnings, it often carries more weight in the investment story.

That balance between the two segments is one reason Aflac tends to attract close attention during earnings season. If both businesses perform reasonably well at the same time, the company has a better chance of posting a beat. If Japan disappoints, however, it can easily overshadow healthier trends in the U.S. operation.

What the Numbers Have Suggested About Earnings Power

Aflac’s recent results show that the company can still produce durable earnings even in a mixed operating environment. In first-quarter 2024, Aflac reported adjusted earnings of $961 million, up 0.8% from a year earlier, while adjusted earnings per diluted share rose 7.1% to $1.66. Net earnings jumped to $1.9 billion, or $3.25 per diluted share, helped by investment gains.

At the same time, the result also showed the complexity of the story. Japan’s net earned premiums fell, but pretax adjusted earnings in dollar terms for the segment still increased 2.8% to $810 million, helped by stronger investment income and better expense efficiency. That combination is exactly why analysts were willing to argue that Aflac’s Japan business could support a stronger-than-expected quarter.

Can Aflac Actually Beat Expectations?

The case for a beat

The bullish case is built on several points. First, expense control in Japan has improved. Second, investment income has shown the ability to provide meaningful support. Third, Aflac has a long-established franchise in Japan with strong market share in cancer and medical insurance. Fourth, new products such as Miraito have shown encouraging momentum in later periods, suggesting that the franchise is still capable of refreshing demand.

Analyst preview coverage also pointed to the possibility that improved expense ratios in Japan could benefit overall margins. When that is combined with Aflac’s history of earnings beats in some prior quarters, the setup becomes more interesting for investors looking for upside surprises.

The case for caution

On the other hand, there are still good reasons to be careful. Premiums in Japan have been under pressure, currency moves can distort reported results, and investment income can be somewhat variable. Even if the underlying business is solid, one or two unfavorable moving parts could keep Aflac from exceeding consensus forecasts. Zacks’ earnings calendar page for Aflac showed a consensus estimate of $1.81 per share for the quarter ending March 2026, illustrating the kind of benchmark investors watch closely going into the report.

So, yes, Aflac may have the ingredients for a beat. But the margin for error is not huge, and much will depend on the exact mix of premium trends, expense performance, and investment income delivered by the Japan operation.

What Investors Should Watch in the Earnings Release

1. Net earned premiums in yen

This will show whether runoff from paid-up policies is still creating major pressure or beginning to stabilize. A smaller decline than expected could be taken positively.

2. Adjusted net investment income

This line can be a major swing factor. Stronger income here may help support earnings even if premiums remain soft.

3. Expense ratio and pretax margin

If Japan continues to show better expense discipline, that could reinforce the view that management is protecting profitability effectively.

4. New annualized premium sales

Sales trends will help investors judge whether new products are gaining traction and whether future premium pressure may ease over time.

5. Management commentary on products and outlook

Forward-looking commentary often shapes the stock reaction as much as the raw numbers. Investors will want to hear how management sees demand, pricing, product launches, and the operating outlook in Japan. Aflac’s investor relations site posts quarterly releases and webcast details for those following the company directly.

Broader Takeaway

Aflac’s Japan business remains the centerpiece of the company’s earnings story. Even in quarters when premium growth is pressured, the unit can still deliver meaningful support through efficient expense management, resilient margins, and solid investment income. That is the heart of the current investment debate. If those strengths show up clearly in the numbers, Aflac could very well turn in a quarter that investors consider impressive.

At the same time, the Japan business is not without challenges. Paid-up policy dynamics, foreign exchange pressure, and uneven sales trends all create noise around the headline results. Because of that, the most useful reading of Aflac’s quarter will likely come from studying the underlying details rather than focusing only on top-line revenue.

Final Analysis

In the end, Aflac’s ability to post a “quack-worthy” first-quarter result may depend less on dramatic revenue growth and more on disciplined execution in Japan. If the company keeps expenses in check, produces healthy investment income, and reassures investors that product demand remains intact, the Japan segment could once again prove why it is so important to the overall business. That would give Aflac a realistic path to delivering results that meet or even exceed market expectations.

Source context: This rewritten article is based on the referenced analyst preview and Aflac investor materials, with added context from company earnings releases and related coverage to provide a fuller, original English-language news analysis. For company filings and earnings materials, Aflac’s investor relations pages are the primary reference point.

#Aflac #JapanBusiness #EarningsPreview #InsuranceStocks #SlimScan #GrowthStocks #CANSLIM